Homo sapiens
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA127567 | ENA |
REPOSITORIES: ENA
Similar Datasets
Project description:Genomic profiling of pancreatic cancer cell lines by array-based comparative genomic hybridization
| PRJNA273356 | ENA
Project description:Cross-Platform Array Comparative Genomic Hybridization (array CGH) Meta-Analysis
| PRJNA96691 | ENA
Project description:Comparative genomic hybridization of BRCAX breast tumors
| PRJNA121465 | ENA
Project description:41 lung adenocarcinoma from never-smokers hybridized on Illumina SNP arrays on 13 HumanCNV370-Quadv3 chips. High-resolution array comparative genomic hybridization analysis of lung adenocarcinoma in 41 never smokers for identification of new minimal common regions (MCR) of gain or loss. The SNP array analysis validated copy-number aberrations and revealed that RB1 and WRN were altered by recurrent copy-neutral loss of heterozygosity.The present study has uncovered new aberrations containing cancer genes. The oncogene FUS is a candidate gene in the 16p region that is frequently gained in never smokers. Multiple genetic pathways defined by gains of MYC, deletions of RB1 and WRN or gains on 7p and 7q are involved in lung adenocarcinoma in never smokers. A 'Cartes d'Identite des Tumeurs' (CIT) project from the French National League Against Cancer (http://cit.ligue-cancer.net) 41 samples hybridized on Illumina SNP arrays. Submitter : Fabien PETEL petelf@ligue-cancer.net . Project leader : Pr Pierre FOURET pierre.fouret@psl.aphp.fr
2011-07-28 | E-TABM-1169 | biostudies-arrayexpress
Project description:Array-comparative genomic hybridization by using DualChip® human cancer 1.1 arrays
| PRJNA106835 | ENA
Project description:Genomic profiling of 49 gastric cancer cell lines by array-based comparative genomic hybridization
| PRJNA301627 | ENA
Project description:HER2 gene amplification and protein overexpression (HER2+) define a clinically challenging subgroup of breast cancer with variable prognosis and response to therapy. Although gene expression profiling has identified an ERBB2 molecular subtype of breast cancer, it is clear that HER2+ tumors reside in all molecular subtypes and represent a genomically and biologically heterogeneous group. Genome-wide DNA copy number profiling, using BAC array comparative genomic hybridization (aCGH) were performed on 200 tumors with mixed clinical characteristics and amplification of HER2. Genomic Identification of Significant Targets in Cancer (GISTIC) was used to identify significant copy number aberrations (CNAs) in HER2+ tumors. This analysis sheds further light on the genomically complex and heterogeneous nature of HER2+ tumors in relation to other subgroups of breast cancer.
2010-04-14 | GSE21259 | GEO
Project description:Array-based Comparative Genomic Hybridization of Melanoma Cell Lines
| PRJNA169352 | ENA
Project description:Understanding Vitamin D resistance using array comparative genomic hybridization
| PRJNA103881 | ENA